PAMELA WINN, APRN
1661 E FLAMINGO RD STE 5A, LAS VEGAS, NV 89119
NPI Number
1235584772
Practice location · View on Google Maps
Total Medicaid Payments
$40,539
-34% vs specialty average
Patients Seen
691
Total Claims
705
$ Per Patient
$59
Specialty avg: $33
Specialty Rank
#66 of 244
Nurse Practitioner, Family providers in Nevada
Peer Average
$61,530
Average total for Nurse Practitioner, Family
Claims per Patient
1.0
Average visits / services per person
Payments by Year
How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.
| Year | Total Paid | % of Max |
|---|---|---|
| 2018 | $40,539 |
Procedure Code Breakdown
The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.
| HCPCS Code | Description | Claims | Paid | % of Total | Avg per Claim |
|---|---|---|---|---|---|
| 99213 | Office visit for a simple problem (established patient) | 462 | $26,630 | 65.7% | $58 |
| 95004 | Allergy testing or treatment | 33 | $9,522 | 23.5% | $289 |
| 96372 | IV infusion or injection of medication | 83 | $3,376 | 8.3% | $41 |
| 92561 | Hearing or speech test or therapy | 17 | $478 | 1.2% | $28 |
| 99188 | Other medical service | 17 | $209 | 0.5% | $12 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 16 | $182 | 0.4% | $11 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 15 | $60 | 0.1% | $4 |
| 85018 | Blood cell or clotting test | 18 | $39 | 0.1% | $2 |
| 81000 | Urinalysis (urine test) | 15 | $31 | 0.1% | $2 |
| J1100 | Injection of dexamethasone (steroid for inflammation, allergies, or breathing problems) | 12 | $12 | 0.0% | $1 |
| 99173 | Other medical service | 17 | $0 | 0.0% | $0 |
About This Data
This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.